-World Health Organization: Director-General’s opening remarks at the media briefing on COVID-19. Presentado en Geneva, Suiza [Internet]. 2020 [citado 20 de mayo de 2020]; Disponible en: https://www.who.int/dg/speeches/detail/whodirector-general-s-opening-remarks-at-the-media-briefing-on-covid-19—11-march-2020

- Wit ED, Doremalen NV, Falzarano D, Munster VJ. SARS and MERS: recent insights into emerging coronaviruses. Nat Rev Microbiol [Internet]. 2016 [citado 20 de mayo de 2020]; 14 (8): 523-534. Disponible en: https://europepmc.org/article/med/27344959

- Wrapp D, Wang N, Corbett KS, Goldsmith JA, Hsieh CL, Abiona O, et al. Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation. Science [Internet]. 2020 [citado 20 de mayo de 2020]; 367(6483):1260-1263. Disponible en: https://www.sciencedirect.com/science/article/pii/S0092867420302622#cebib0010

- Xiong TY, Redwood S, Prendergast B, Chen M. Coronaviruses and the cardiovascular system: acute and long-term implications. Eur Heart J [Internet]. 2020 [citado 20 de mayo de 2020]; 41 (19): 1978-1800. Disponible en: https://doi.org/10.1093/eurheartj/ehaa231

- Moreno-Martínez FL, Moreno-López FL, Moreno RO. Reprecusión cardiovascular de la infección por el nuevo coronavirus SARS-CoV-2 (COVID-19). Corsalud [Internet]. 2020 [citado 20 de mayo de 2020]; 12 (1): 3-17. Disponible en: http://www.revcorsalud.sld.cu/index.php/cors/article/view/588/1113

- Bansal M. Cardiovascular disease and COVID-19. Diabetes Metab Syndr [Internet]. 2020 [citado 20 de mayo de 2020]; 14(3):247-50. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7102662/

- Henry C, Zaizafoun M, Stock E, Ghamande S, Arroliga AC, White HD. Impact of angiotensin converting enzyme inhibitors and statins on viral pneumonia. Bayl Univ Med Cent Proc [Internet].2018 [citado 20 de mayo de 2020]; 31(4):419-23. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6414001/

- Deshotels MR, Xia H, Sriramula S, Lazartigues E, Filipeanu CM. Angiotensin II mediates angiotensin converting enzyme type 2 internalization and degradation through an angiotensin II type I receptor-dependent mechanism. Hypertension [Internet]. 2014 [citado 20 de mayo de 2020]; 64(6): 1368-1375. Disponible en: https://www.ahajournals.org/doi/full/10.1161/hypertensionaha.114.03743